Association of Impaired Reactive Aldehyde Metabolism with Delayed Graft Function in Human Kidney Transplantation
Table 1
Patient characteristics for gene array studies.
Living donor kidney transplant ()
Deceased donor kidney transplant ()
Age of recipient (yrs)
49 ± 5
56 ± 4
Sex of recipient (% males)
60%
50%
Age of donor (yrs)
52 ± 2
49 ± 6
Sex of donor (% males)
30%
75%
Cold ischemia time (min)
213 ± 12
1001 ± 96
Hospital stay (days)
8 ± 1
15 ± 2
Recipient cause of renal failure
Glomerulonephritis
40%
12.5%
Polycystic kidney disease
20%
25%
Diabetes mellitus type 2
10%
12.5%
Obstructive uropathy
10%
0%
Malignant hypertension
0%
0%
Renal failure
20%
50%
Donor cause of death
Living donor
100%
CVA
0%
SAB
25%
Trauma
37.5%
CA-OHCA-AMI
25%
Suicide
0%
Miscellaneous
12.5%
Histocompatibility (HLA mismatches, %)
0
10%
12.5%
1
10%
25%
2
10%
25%
3
20%
25%
4
20%
12.5%
5
20%
0%
6
10%
0%
A total of 18 patients were included. When comparing recipients of a living donor transplant to recipients of a deceased donor transplant, significant differences were noted for duration of ischemia time, and length of posttransplantation hospital stay. , CVA = cerebral vascular accident, SAB = subarachnoid bleeding, CA = cardiac arrest, OHCA = out of hospital cardiac arrest, AMI = acute myocardial infarction. Data represents mean ± SEM.
